Enskyce is a low-dose birth control pill. Each active tablet contains 30 mcg of ethinyl estradiol (the estrogen component) and 0.15 mg of desogestrel (the progestin component), placing it squarely within the low-dose category as defined in clinical practice.
What Counts as “Low-Dose”
In medical terms, any combination birth control pill containing less than 50 mcg of ethinyl estradiol qualifies as low-dose. Most pills prescribed today fall in the 20 to 35 mcg range. At 30 mcg, Enskyce sits in the middle of that window, neither the lowest estrogen option available nor the highest.
Pills with 10 to 20 mcg of ethinyl estradiol are sometimes called “ultra-low-dose.” These carry a lower overall estrogen exposure but tend to cause more breakthrough bleeding, especially in the first few months. Enskyce’s 30 mcg dose strikes a balance: enough estrogen to keep your cycle predictable, while still being well below the 50 mcg threshold of older formulations from the 1960s and 70s.
What’s in Each Tablet
Enskyce is a monophasic pill, meaning every active tablet delivers the same hormone levels. Each pack contains 21 light orange active tablets with 0.15 mg of desogestrel and 0.03 mg (30 mcg) of ethinyl estradiol, followed by 7 inactive (placebo) tablets for the week you have your period. Because the dose stays constant across all active pills, there’s no specific order concern beyond taking one pill daily.
How Enskyce Prevents Pregnancy
Like other combination pills, Enskyce works through three mechanisms. The primary one is stopping ovulation: the hormones suppress the signals from your brain that normally trigger your ovaries to release an egg each month. As a backup, the progestin thickens cervical mucus, making it harder for sperm to reach the uterus. It also thins the uterine lining, reducing the likelihood of a fertilized egg implanting.
With perfect use (taking the pill at the same time every day, no missed doses), the failure rate is about 0.3% in the first year. With typical use, which accounts for the occasional missed pill or late start, that number rises to about 9%.
How 30 mcg Compares to Other Doses
If you’re weighing Enskyce against other pills, the estrogen dose is one of the main variables that affects both side effects and cycle control. Here’s how the common tiers break down:
- Ultra-low-dose (10 to 20 mcg): Lowest estrogen exposure, but more likely to cause spotting or breakthrough bleeding, particularly in the first three months.
- Low-dose (30 to 35 mcg): Where Enskyce falls. Generally good cycle control with a moderate estrogen level. This range is the most commonly prescribed.
- Regular-dose (50 mcg): Rarely prescribed today. Higher estrogen means more predictable periods but a greater risk of estrogen-related side effects like blood clots, headaches, and bloating.
The progestin type matters too. Enskyce uses desogestrel, a third-generation progestin. Desogestrel tends to have fewer androgenic effects (like acne or excess hair growth) compared to older progestins, though individual responses vary.
Who Should Avoid Enskyce
Enskyce carries the same restrictions as other combination pills. The most significant is for smokers over 35: the combination of estrogen, nicotine, and age sharply increases the risk of serious cardiovascular events like heart attacks and strokes. If you’re over 35 and smoke, combination pills including Enskyce are not an option.
Other situations where Enskyce is not appropriate include a history of blood clots or clotting disorders, coronary artery disease or stroke, uncontrolled high blood pressure (persistently at or above 160/100), diabetes with blood vessel damage, a history of hormone-sensitive breast cancer, liver disease or liver tumors, and migraines with visual disturbances or other neurological symptoms. If you’re scheduled for major surgery that will keep you immobilized for an extended period, you’ll typically need to stop the pill ahead of time because immobility combined with estrogen raises clot risk.
The overall risk of complications also goes up when multiple factors overlap, such as having both high blood pressure and obesity, or diabetes alongside high cholesterol. In those cases, a progestin-only method or a non-hormonal option may be a better fit.